Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of PET staging in limited-stage small-cell lung cancer.
Xanthopoulos EP, Corradetti MN, Mitra N, Fernandes AT, Kim M, Grover S, Christodouleas JP, Evans TL, Stevenson JP, Langer CJ, Lee TT, Pryma DA, Lin LL, Simone CB 2nd, Apisarnthanarax S, Rengan R. Xanthopoulos EP, et al. J Thorac Oncol. 2013 Jul;8(7):899-905. doi: 10.1097/JTO.0b013e31828e8996. J Thorac Oncol. 2013. PMID: 23608814 Free article.
Five-year Long-term Outcomes of Stereotactic Body Radiation Therapy for Operable Versus Medically Inoperable Stage I Non-small-cell Lung Cancer: Analysis by Operability, Fractionation Regimen, Tumor Size, and Tumor Location.
Schonewolf CA, Heskel M, Doucette A, Singhal S, Frick MA, Xanthopoulos EP, Corradetti MN, Friedberg JS, Pechet TT, Christodouleas JP, Levin W, Berman A, Cengel KA, Verma V, Hahn SM, Kucharczuk JC, Rengan R, Simone CB 2nd. Schonewolf CA, et al. Among authors: xanthopoulos ep. Clin Lung Cancer. 2019 Jan;20(1):e63-e71. doi: 10.1016/j.cllc.2018.09.004. Epub 2018 Sep 20. Clin Lung Cancer. 2019. PMID: 30337269
The impact of extent and location of mediastinal lymph node involvement on survival in Stage III non-small cell lung cancer patients treated with definitive radiotherapy.
Fernandes AT, Mitra N, Xanthopoulos E, Evans T, Stevenson J, Langer C, Kucharczuk JC, Lin L, Rengan R. Fernandes AT, et al. Among authors: xanthopoulos e. Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):340-7. doi: 10.1016/j.ijrobp.2011.05.070. Epub 2011 Nov 19. Int J Radiat Oncol Biol Phys. 2012. PMID: 22104359
Brachial plexopathy in apical non-small cell lung cancer treated with definitive radiation: dosimetric analysis and clinical implications.
Eblan MJ, Corradetti MN, Lukens JN, Xanthopoulos E, Mitra N, Christodouleas JP, Grover S, Fernandes AT, Langer CJ, Evans TL, Stevenson J, Rengan R, Apisarnthanarax S. Eblan MJ, et al. Among authors: xanthopoulos e. Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):175-81. doi: 10.1016/j.ijrobp.2012.03.051. Epub 2012 Jun 1. Int J Radiat Oncol Biol Phys. 2013. PMID: 22658442
Intensity-modulated proton therapy for elective nodal irradiation and involved-field radiation in the definitive treatment of locally advanced non-small-cell lung cancer: a dosimetric study.
Kesarwala AH, Ko CJ, Ning H, Xanthopoulos E, Haglund KE, O'Meara WP, Simone CB 2nd, Rengan R. Kesarwala AH, et al. Among authors: xanthopoulos e. Clin Lung Cancer. 2015 May;16(3):237-44. doi: 10.1016/j.cllc.2014.12.001. Epub 2014 Dec 9. Clin Lung Cancer. 2015. PMID: 25604729 Free PMC article.
23 results